Alqinyah M., Hooks S.B.* (2017) Regulating the regulators: Epigenetic, transcriptional, and post-translational regulation of RGS proteins. Cell Signal. 42:77-87. doi: 10.1016/j.cellsig.2017.10.007. PMID: 29042285. (Impact factor: 3.937, review)
Alqinyah, M., Maganti, N., Ali, M.W., Yadav, R., Gao, M., Weng, H-R., Greer, S.F., Hooks, S.B.* (2017) Regulator of G-protein Signaling 10 (Rgs10) expression is transcriptionally silenced in activated microglia by histone deacetylase activity. Molecular Pharmacology, 91(3) 197-207. DOI: https://doi.org/10.1124/mol.116.106963. (Impact factor: 3.9, research article)
Callihan P., Alqinyah, M., Hooks, S.B.* S1P Signaling in Human Neural Progenitors. Sphingosine 1-Phosphate Signaling: Methods and Protocols. Ed: Turksen, K., Pebay, A. Humana Press, 2017. (book chapter)
Alqinyah, M., Maganti, N., Ali, M.W., Yadav, R., Gao, M., Weng, H-R., Greer, S.F., Hooks, S.B.* (2016) Regulator of G-protein Signaling 10 (Rgs10) expression is transcriptionally silenced in activated microglia by histone deacetylase activity. Molecular Pharmacology, mol.116.106963; DOI: https://doi.org/10.1124/mol.116.106963
Maixner, D.W., Yan, X., Hooks, S.B., Weng, H.-R.* (2016) AMPKα1 knockout enhances nociceptive behaviors and spinal glutamatergic synaptic activities via production of reactive oxygen species in the spinal dorsal horn. Neuroscience, 326 (21): 158-169.
Hooks, S. B., & Murph, M. M.* (2015). Cellular deficiency in the RGS10 protein facilitates chemoresistant ovarian cancer. Future Medicinal Chemistry, 7(12), 1483-1489.
Hung S.W., Marrache S., Cummins S., Bhutia Y.D., Mody H., Hooks S.B., Dhar S., Govindarajan R. (2015) Defective hCNT1 transport contributes to gemcitabine chemoresistance in ovarian cancer subtypes: Overcoming transport defects using a nanoparticle approach. Cancer Letters, 359(2):233-40.
Tuggle, K., Ali, M.W., Salazar, H., Hooks, S.B. (2014) Regulator of G-protein Signaling (RGS) transcript expression in human neural progenitor differentiation: R7 subfamily regulation by DNA methylation. NeuroSignals, 22(43-51).
Calihan, C.P., Ali, M., Salazar, H., Quach, N. Wu, X., Stice, S.L., Hooks, S.B. (2014) Convergent regulation of neuronal differentiation and Erk and Akt kinases in human neural progenitor cells by Lysophosphatidic Acid, Sphingosine 1-phosphate, and LIF: specific roles for the LPA1 receptor. ASN Neuro, 6(6): 1759091414558416.
Cacan, E., Ali, M.A., Boyd, N.H., Hooks, S.B., Greer, S.F. (2014) Inhibition of HDAC1 and DNMT1 modulate RGS10 expression and decrease ovarian cancer chemoresistance.PLOS One, 9 (1): e87455. PMID: 24475290.
Ali, M.W., Cacan, E., Liu, Y., Pierce, J.Y., Creasman, W.T., Murph, M.M., Govindarajan, R., Eblen, S.T., Greer, S.F, and Hooks, S.B.* (2013) Transcriptional suppression, DNA methylation, and histone deacetylation of the Regulator of G-protein Signaling 10 (RGS10) gene in ovarian cancer cells. PLOS One, 8 (3) e60185. PMID: 23533674.
Callihan, C. P., Zitomer, N.C., Stoeling, M.V., Kennedy, P.C., Lynch, K.R., Riley, R.T.,Hooks, S.B. (2011) Distinct generation, pharmacology, and distribution of sphingosine 1-phosphate and dihydro-sphingosine 1-phosphate in human neural progenitor cells.Neuropharmacology, 62 (2):988-96.
Callihan, C.P., Mumaw, J., Machacek, D.W., Stice, S.L., Hooks, S.B.* (2010) Regulation of stem cell pluripotency and differentiation by G-protein coupled receptors. Pharmacology and Therapeutics, 129 (3):290-306.
Hooks, S.B.*, Callihan, C.P., Altman, M., Ali, M., Hurst, J.H., Murph, M.M. (2010) Regulators of G-protein Signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells. Molecular Cancer, 9:289.
Hurst, J.H., and Hooks, S.B.* (2009) Regulator of G-protein Signaling (RGS) proteins in Cancer Biology. Biochemical Pharmacology, 78 (10):1289-97.
Hurst, J.H., Machacek, D., Stice, S.L. and Hooks, S.B.* (2008) Human neural progenitors express functional lysophospholipid receptors that regulate cell growth and morphology.BMC Neuroscience, 11(9): 118.
Hurst, J.H., Henkel, P.A., Brown, A.L., Hooks, S.B.* (2008) Endogenous RGS Proteins Attenuate Galpha(i)-mediated Lysophosphatidic Acid Signaling Pathways in Ovarian Cancer Cells, Cellular Signaling, 20(2), 381-9.